Power Life Sciences

Open enrollment across a mixed-phase pipeline

According to ClinicalTrials.gov-derived indexes, Power Life Sciences sits in the top decile of US sponsors by registered trial count (#332 of 15,742 sponsors by registered trial count).

62 total trials 1 currently recruiting top decile by trial count

Power Life Sciences: 62 sponsored US clinical trials, 1 recruiting.

Power Life Sciences sponsors 62 registered US clinical trials on ClinicalTrials.gov, 1 of them currently recruiting. The most-studied condition in this pipeline is OCD, with 1 trials.

Top-decile sponsor footprint

Power Life Sciences ranks in the top decile of sponsors by registered trial count (#332 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

What is open in the Power Life Sciences pipeline

1 recruiting of 62 indexed (2% open).

Phase labels are sparse on this sponsor index, so phase mix is not charted here.

Top condition: OCD (1 trial), 1 other listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

Power Life Sciences: open-pipeline peers nationwide

Peers matched on 62 registered trials and 2% open enrollment, not the therapeutic-area sidebar.

Power Life Sciences sits below the median trial volume and below the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 0100200300 0%2%4%6%8%10% Total trials Recruiting share Power Life SciencesOregon Research InstituteActelionHennepin Healthcare Research InstituteUnited TherapeuticsBausch & Lomb IncorporatedMedtronic Cardiac Rhythm and Heart FailureEisaiLexicon Pharmaceuticals
Power Life Sciences sits below the median trial volume and below the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

Power Life Sciences sits below the median trial volume and below the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 62 trials (± recruiting share)

Sponsors near 2% open enrollment (± trial volume)

What to do with this Power Life Sciences page

62 registered trials is a research-attention snapshot, not an endorsement of Power Life Sciences or any single study.

  • 1 of Power Life Sciences's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • OCD is the condition Power Life Sciences studies most, compare against other sponsors active in the same condition before evaluating a specific study. See OCD trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Power Life Sciences pipeline card: 62 registered trials from official public datasets.Report a data error.